EC Number |
Inhibitors |
Structure |
---|
3.4.21.75 | (1R,3S,4S,6R)-4-(2-carbamimidoylhydrazinyl)-6-guanidinocyclohexane-1,3-diyl bis(3-guanidinophenylcarbamate) |
- |
|
3.4.21.75 | (1R,3S,4S,6R)-4-(2-carbamimidoylhydrazinyl)-6-guanidinocyclohexane-1,3-diyl bis(4-guanidinophenylcarbamate) |
- |
|
3.4.21.75 | (1S,14S,17S,20S,23S,26S,33r)-26-amino-N-(4-carbamimidoylbenzyl)-20,23-bis(3-guanidinopropyl)-17-neopentyl-4,8,16,19,22,25,32-heptaoxo-3,9,15,18,21,24,31-heptaazabicyclo[31.2.2]heptatriacontane-14-carboxamide |
- |
|
3.4.21.75 | (D-Arg)6 amide |
IC50: 0.3 mM |
|
3.4.21.75 | (D-Arg)9 amide |
IC50: 0.01 mM |
|
3.4.21.75 | (D-Arg)9-amide |
protects RAW264.7 cells against anthrax toxemia with an IC50 of 0.0037 mM |
|
3.4.21.75 | (E)-N-((E)-5-(2-chloro-5-nitrobenzylidene)-4-oxothiazolidin-2-ylidene)-4-methylbenzenesulfonamide |
competitive inhibitor |
|
3.4.21.75 | (N'Z,N''Z)-4,4'-oxybis(N'-(2-hydroxybenzylidene)benzenesulfonohydrazide) |
competitive inhibitor |
|
3.4.21.75 | 1,1'-((1R,3S,4S,6R)-4,6-bis(4-guanidinophenoxy)cyclohexane-1,3-diyl)diguanidine |
meso compound |
|
3.4.21.75 | 1,1'-((1R,3S,4S,6R)-4-((4-guanidinonaphthalen-1-yl)oxy)-6-(4-guanidinophenoxy)cyclohexane-1,3-diyl)diguanidine |
racemate, blocks the S2 pocket |
|